Mycophenolic acid counteracts B cell proliferation and plasmablast formation in patients with systemic lupus erythematosus

[11] Aranow C(2000)Disturbed peripheral B lymphocyte homeostasis in systemic lupus erythematosus J Immunol 165 5970-27290

[12] Diamond B(2001)Increased frequency of pre-germinal center B cells and plasma cell precursors in the blood of children with systemic lupus erythematosus J Immunol 167 2361-261

[13] Davidson A(1993)Characterization of human type I and type II IMP dehydrogenases J Biol Chem 268 27286-5520

[14] Huang H(1992)Proliferation-linked regulation of type II IMP dehydrogenase gene in human normal lymphocytes and HL-60 leukemic cells Cancer Res 52 258-232

[15] Benoist C(1985)Biochemical differences among four inosinate dehydrogenase inhibitors, mycophenolic acid, ribavirin, tiazofurin, and selenazofurin, studied in mouse lymphoma cell culture Cancer Res 45 5512-173

[16] Mathis D(1995)Mycophenolate mofetil for the prevention of acute rejection in primary cadaveric renal allograft recipients. U.S. Renal Transplant Mycophenolate Mofetil Study Group Transplantation 60 225-147

[17] Miller JJ(1991)Lymphocyte-selective cytostatic and immunosuppressive effects of mycophenolic acid in vitro: role of deoxyguanosine nucleotide depletion Scand J Immunol 33 161-513

[18] Cole LJ(2006)Inosine 5'-monophosphate dehydrogenase inhibition by mycophenolic acid impairs maturation and function of dendritic cells Clin Chim Acta 364 139-2381

[19] Appel GB(2009)Mycophenolic acid impedes the antigen presenting and lymph node homing capacities of human blood myeloid dendritic cells Transplantation 88 504-4815

[20] Contreras G(2000)Mycophenolate mofetil impairs the maturation and function of murine dendritic cells J Immunol 165 2374-171

[11] Aranow C(2000)Disturbed peripheral B lymphocyte homeostasis in systemic lupus erythematosus J Immunol 165 5970-27290

[12] Diamond B(2001)Increased frequency of pre-germinal center B cells and plasma cell precursors in the blood of children with systemic lupus erythematosus J Immunol 167 2361-261

[13] Davidson A(1993)Characterization of human type I and type II IMP dehydrogenases J Biol Chem 268 27286-5520

[14] Huang H(1992)Proliferation-linked regulation of type II IMP dehydrogenase gene in human normal lymphocytes and HL-60 leukemic cells Cancer Res 52 258-232

[15] Benoist C(1985)Biochemical differences among four inosinate dehydrogenase inhibitors, mycophenolic acid, ribavirin, tiazofurin, and selenazofurin, studied in mouse lymphoma cell culture Cancer Res 45 5512-173

[16] Mathis D(1995)Mycophenolate mofetil for the prevention of acute rejection in primary cadaveric renal allograft recipients. U.S. Renal Transplant Mycophenolate Mofetil Study Group Transplantation 60 225-147

[17] Miller JJ(1991)Lymphocyte-selective cytostatic and immunosuppressive effects of mycophenolic acid in vitro: role of deoxyguanosine nucleotide depletion Scand J Immunol 33 161-513

[18] Cole LJ(2006)Inosine 5'-monophosphate dehydrogenase inhibition by mycophenolic acid impairs maturation and function of dendritic cells Clin Chim Acta 364 139-2381

[19] Appel GB(2009)Mycophenolic acid impedes the antigen presenting and lymph node homing capacities of human blood myeloid dendritic cells Transplantation 88 504-4815

[20] Contreras G(2000)Mycophenolate mofetil impairs the maturation and function of murine dendritic cells J Immunol 165 2374-171